Nonetheless, although CD36 deficiency is associated with reduced risks for cardiovascular diseases, the morbidity of CAD is significantly higher in CD36 deficiency patients suffering from severe atherosclerosis [61], implying that the status of CD36 deficiency might be atherogenic rather than VSMC contraction-prone. Here, CD36 is linked to coronary artery disorder.